Brestel E P, Thrush L B
Department of Medicine, West Virginia University School of Medicine, Morgantown.
J Allergy Clin Immunol. 1988 Aug;82(2):265-9. doi: 10.1016/0091-6749(88)91010-x.
In this study, four patients presented with chronic urticaria that required glucocorticosteroid therapy for control. In the first patient, the urticaria began during pregnancy and persisted after delivery with symptoms flaring premenstrually thereafter. Danazol was selected in an attempt to suppress progesterone levels, theoretically by inhibiting ovulation. The patient's urticaria markedly improved, however, within 24 hours. Several months later, she was switched to stanozolol with further improvement. Three other individuals were treated with stanozolol with dramatic improvement. In all, three patients have experienced the induction of five remissions (there were two recurrences), and one patient remains much improved. All subjects have stopped both stanozolol and glucocorticosteroids. Stanozolol appears to act synergistically with glucocorticosteroids, and together, they may be capable of inducing remission in some patients.
在本研究中,有4例慢性荨麻疹患者需要糖皮质激素治疗来控制病情。首例患者的荨麻疹始于孕期,产后持续存在,此后在经前症状加重。选用达那唑试图抑制孕酮水平,理论上是通过抑制排卵来实现。然而,患者的荨麻疹在24小时内明显改善。几个月后,她改用司坦唑醇,病情进一步改善。另外3例患者接受司坦唑醇治疗后病情显著改善。总体而言,3例患者实现了5次病情缓解(有2次复发),1例患者病情仍有很大改善。所有受试者均已停用司坦唑醇和糖皮质激素。司坦唑醇似乎与糖皮质激素起协同作用,二者共同作用或许能够使部分患者病情缓解。